The use of marijuana (Cannabis sativa L.) in the pharmaceutical industry: a review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/19829 |
Resumo: | The aim of the present study was to expose, through an integrative literature review, the importance of using active principles derived from marijuana (Cannabis sativa) in the pharmaceutical industry. An integrative literature review was carried out. It was adopted as a criterion that include scientific documents, which presented a relationship with the application of marijuana in the pharmaceutical industry in a time frame between 2006 and 2021, in order to discuss the scientific evidence of the last fifteen years. The use of active compounds from Cannabis sativa in the industry is still something little explored, especially in Brazil. One of the main factors that contributes to the lack of interest in the use of marijuana is the illicit recreational use of marijuana. But this is being released for cultivation and studies by competent companies, and may bring a series of benefits to both human health and pharmaceutical industries. It has numerous therapeutic actions related to secondary metabolites. It is worth highlighting the proven effects against diseases such as epilepsy, anxiety, depression, Parkinson's disease, multiple sclerosis and headache. For these reasons, in line with the world trend in which it is clear that consumers are prioritizing the use of natural-based products, showing the wide field of study and technology for further study developments. |
id |
UNIFEI_8dd717ca358d39cf54888144de14cc71 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/19829 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
The use of marijuana (Cannabis sativa L.) in the pharmaceutical industry: a reviewEl uso de marihuana (Cannabis sativa L.) en la industria farmacéutica: una revisiónO uso da maconha (Cannabis sativa L.) na indústria farmacêutica: uma revisão Medicinal MarijuanaCannabisActive principleHerbal medicinesIntegrative review.Marihuana medicinalCannabisPrincipio activoHierbas medicinalesRevisión integradora.Maconha MedicinalCannabisPrincípio ativoFitoterápicosRevisão integrativa.The aim of the present study was to expose, through an integrative literature review, the importance of using active principles derived from marijuana (Cannabis sativa) in the pharmaceutical industry. An integrative literature review was carried out. It was adopted as a criterion that include scientific documents, which presented a relationship with the application of marijuana in the pharmaceutical industry in a time frame between 2006 and 2021, in order to discuss the scientific evidence of the last fifteen years. The use of active compounds from Cannabis sativa in the industry is still something little explored, especially in Brazil. One of the main factors that contributes to the lack of interest in the use of marijuana is the illicit recreational use of marijuana. But this is being released for cultivation and studies by competent companies, and may bring a series of benefits to both human health and pharmaceutical industries. It has numerous therapeutic actions related to secondary metabolites. It is worth highlighting the proven effects against diseases such as epilepsy, anxiety, depression, Parkinson's disease, multiple sclerosis and headache. For these reasons, in line with the world trend in which it is clear that consumers are prioritizing the use of natural-based products, showing the wide field of study and technology for further study developments.El objetivo del presente estudio fue exponer, a través de una revisión integradora de la literatura, la importancia del uso de principios activos derivados de la marihuana (Cannabis sativa) en la industria farmacéutica. Para este tipo de revisión integradora de la literatura se llevó a cabo. Se adoptó como criterio que incluya documentos de carácter científico, que presentaran una relación con la aplicación de la marihuana en la industria farmacéutica en un marco temporal entre 2006 y 2021, con el fin de discutir la evidencia científica de los últimos quince años. El uso de compuestos activos de Cannabis sativa en la industria aún es algo poco explorado, especialmente en Brasil. Uno de los principales factores que contribuye a la falta de interés por el uso de la marihuana es el uso recreativo ilícito de la marihuana. Tiene numerosas acciones terapéuticas relacionadas con los metabolitos secundarios. Cabe destacar los efectos probados frente a enfermedades como la epilepsia, la ansiedad, la depresión, la enfermedad de Parkinson, la esclerosis múltiple y el dolor de cabeza. Por estos motivos, en línea con la tendencia mundial en la que es evidente que los consumidores están priorizando el uso de productos de base natural, mostrando el amplio campo de estudio y tecnología para futuros desarrollos de estudios.O objetivo do presente estudo foi expor por meio de uma revisão integrativa da literatura a importância do uso dos princípios ativos advindos da maconha (Cannabis sativa) na indústria farmacêutica. Para tal uma revisão integrativa de literatura foi realizada. Adotou-se como critério que incluam documentos de cunho cientifico, que apresentou relação com a aplicação da maconha na indústria farmacêutica em um recorte temporal entre 2006 a 2021, como intuito em discorrer sobre as evidências científicas dos últimos quinze anos. A utilização dos compostos ativos da Cannabis sativa na indústria ainda é algo pouco explorado, principalmente no Brasil. Um dos principais fatores de que contribui para que não haja maior interesse em torno da utilização da maconha é o uso recreativo ilícito da mesma. Mas esta está sendo liberada para cultivo e estudos de empresas competentes, podendo trazer uma série de benefícios tanto a saúde humana, quando para as indústrias farmacêuticas. A mesma apresenta numerosas ações terapêuticas relacionadas aos metabolitos secundários. É valido ressaltar os efeitos comprovados frente a doenças como epilepsia, ansiedade, depressão, doença de Parkinson, esclerose múltipla e cefaleia. Por esses motivos em concordância com a tendência mundial a qual é notório que os consumidores estão priorizando o uso de produtos à base natural, mostrando o amplo campo de estudo e tecnológicos para desenvolvimentos de estudos posteriores.Research, Society and Development2021-09-13info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1982910.33448/rsd-v10i12.19829Research, Society and Development; Vol. 10 No. 12; e46101219829Research, Society and Development; Vol. 10 Núm. 12; e46101219829Research, Society and Development; v. 10 n. 12; e461012198292525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/19829/17958Copyright (c) 2021 Amanda Alves de Lima; Ueslane Coelho Alexandre; Jânio Sousa Santoshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessLima, Amanda Alves deAlexandre, Ueslane Coelho Santos, Jânio Sousa 2021-11-14T20:26:51Zoai:ojs.pkp.sfu.ca:article/19829Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:39:38.789856Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
The use of marijuana (Cannabis sativa L.) in the pharmaceutical industry: a review El uso de marihuana (Cannabis sativa L.) en la industria farmacéutica: una revisión O uso da maconha (Cannabis sativa L.) na indústria farmacêutica: uma revisão |
title |
The use of marijuana (Cannabis sativa L.) in the pharmaceutical industry: a review |
spellingShingle |
The use of marijuana (Cannabis sativa L.) in the pharmaceutical industry: a review Lima, Amanda Alves de Medicinal Marijuana Cannabis Active principle Herbal medicines Integrative review. Marihuana medicinal Cannabis Principio activo Hierbas medicinales Revisión integradora. Maconha Medicinal Cannabis Princípio ativo Fitoterápicos Revisão integrativa. |
title_short |
The use of marijuana (Cannabis sativa L.) in the pharmaceutical industry: a review |
title_full |
The use of marijuana (Cannabis sativa L.) in the pharmaceutical industry: a review |
title_fullStr |
The use of marijuana (Cannabis sativa L.) in the pharmaceutical industry: a review |
title_full_unstemmed |
The use of marijuana (Cannabis sativa L.) in the pharmaceutical industry: a review |
title_sort |
The use of marijuana (Cannabis sativa L.) in the pharmaceutical industry: a review |
author |
Lima, Amanda Alves de |
author_facet |
Lima, Amanda Alves de Alexandre, Ueslane Coelho Santos, Jânio Sousa |
author_role |
author |
author2 |
Alexandre, Ueslane Coelho Santos, Jânio Sousa |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Lima, Amanda Alves de Alexandre, Ueslane Coelho Santos, Jânio Sousa |
dc.subject.por.fl_str_mv |
Medicinal Marijuana Cannabis Active principle Herbal medicines Integrative review. Marihuana medicinal Cannabis Principio activo Hierbas medicinales Revisión integradora. Maconha Medicinal Cannabis Princípio ativo Fitoterápicos Revisão integrativa. |
topic |
Medicinal Marijuana Cannabis Active principle Herbal medicines Integrative review. Marihuana medicinal Cannabis Principio activo Hierbas medicinales Revisión integradora. Maconha Medicinal Cannabis Princípio ativo Fitoterápicos Revisão integrativa. |
description |
The aim of the present study was to expose, through an integrative literature review, the importance of using active principles derived from marijuana (Cannabis sativa) in the pharmaceutical industry. An integrative literature review was carried out. It was adopted as a criterion that include scientific documents, which presented a relationship with the application of marijuana in the pharmaceutical industry in a time frame between 2006 and 2021, in order to discuss the scientific evidence of the last fifteen years. The use of active compounds from Cannabis sativa in the industry is still something little explored, especially in Brazil. One of the main factors that contributes to the lack of interest in the use of marijuana is the illicit recreational use of marijuana. But this is being released for cultivation and studies by competent companies, and may bring a series of benefits to both human health and pharmaceutical industries. It has numerous therapeutic actions related to secondary metabolites. It is worth highlighting the proven effects against diseases such as epilepsy, anxiety, depression, Parkinson's disease, multiple sclerosis and headache. For these reasons, in line with the world trend in which it is clear that consumers are prioritizing the use of natural-based products, showing the wide field of study and technology for further study developments. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-09-13 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/19829 10.33448/rsd-v10i12.19829 |
url |
https://rsdjournal.org/index.php/rsd/article/view/19829 |
identifier_str_mv |
10.33448/rsd-v10i12.19829 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/19829/17958 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2021 Amanda Alves de Lima; Ueslane Coelho Alexandre; Jânio Sousa Santos https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2021 Amanda Alves de Lima; Ueslane Coelho Alexandre; Jânio Sousa Santos https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 12; e46101219829 Research, Society and Development; Vol. 10 Núm. 12; e46101219829 Research, Society and Development; v. 10 n. 12; e46101219829 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052788894597120 |